XML 42 R32.htm IDEA: XBRL DOCUMENT

Shareholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2024

Schedule of Stockholders' Equity Note, Warrants or Rights

A summary of the Company’s outstanding warrants as of March 31, 2024, are presented below (in thousands, except number of shares and exercise price):


	Number of Shares	Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Outstanding as of December 31, 2023	166,670	$	17.40	$	—	8.6



Outstanding as of March 31, 2024	166,670	$	17.40	$	—	8.3

Share-based Payment Arrangement, Expensed and Capitalized, Amount

During the three months ended March 31, 2024 and 2023, the Company recognized stock-based compensation expense as follows (in thousands):


	Three Months Ended March 31,
		2024		2023
Subscriber related		$	79	$	52
Sales and marketing		4,707		6,673
Technology and development		3,878		3,042
General and administrative		4,313		3,921
		$	12,977	$	13,688

Share-based Payment Arrangement, Activity

A summary of stock option activity for the three months ended March 31, 2024 is as follows (in thousands, except share and per share amounts):


	Number of Shares	Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Outstanding as of December 31, 2023	10,475,607	$	6.31	$	6,534	5.3

Exercised	(2,042)	$	1.24
Forfeited or expired	(94,562)	$	9.98
Outstanding as of March 31, 2024	10,379,003	$	6.28	$	1,476	5.1

Options vested and exercisable as of March 31, 2024	9,593,284	$	6.45	$	1,476	5.5

A summary of activity under the 2020 Plan for market and service-based stock options for the three months ended March 31, 2024 is as follows (in thousands, except share and per share amounts):


	Number of Shares	Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Outstanding as of December 31, 2023	4,453,297	$	12.75	$	—	3.7

Outstanding as of March 31, 2024	4,453,297	$	12.75	$	—	3.4

Options vested and exercisable as of March 31, 2024	3,994,964	$	11.96	$	—	3.3

Schedule of Nonvested Restricted Stock Units Activity

A summary of the Company’s time-based restricted stock unit activity during the three months ended March 31, 2024 is as follows:


	Number of Shares	Weighted Average Grant-Date Fair Value
Unvested at December 31, 2023	20,313,775	$	3.85
Granted	258,865	$	2.03
Vested	(507,198)	$	6.77
Forfeited or expired	(465,551)	$	3.98
Unvested at March 31, 2024	19,599,891	$	3.75

A summary of the Company’s performance-based restricted stock unit activity during the three months ended March 31, 2024 is as follows:


	Number of Shares	Weighted Average Grant-Date Fair Value
Unvested at December 31, 2023	2,035,834	$	20.23
Granted	335,924	$	1.54


Unvested at March 31, 2024	2,371,758	$	17.58